Shortage of 'Apidra' insulin for diabetes patients in Pakistan
Published
Diabetes patients in Pakistan are facing a significant medical issue, as a severe shortage of an insulin brand called 'Apidra' is being observed in the market. This insulin is used to control blood sugar levels in both children and adults, and its scarcity poses a risk to the health of patients.
Apidra is a rapid-acting insulin that helps balance blood sugar immediately after meals. According to health experts, the unavailability of this medication is a cause for concern for patients who use it as part of their daily regimen.
In view of this situation, doctors have advised patients to consult their physicians instead of making any decisions on their own. Doctors can provide better guidance regarding alternative treatments or the use of other insulin based on the patient's condition.
Authorities are working on the reasons behind this shortage to ensure the supply of the medicine in the market as soon as possible. Patients and their families have been instructed to avoid purchasing medicine from any unverified sources and to only consult authorized pharmacies.
Sources: Brandsynario
More Pakistan news
- China's Industrial Development Becomes a Focus of Global Business Interest
- Crackdown on Online Fraud in Cambodia, but the Industry's Global Spread Continues
- The Role of Artificial Intelligence in Making Ride-Hailing Services Safer in Pakistan
- Islamabad High Court Orders Meeting Between Imran Khan, Bushra Bibi and Their Lawyers
- Health Minister says no public funds were wasted in vaccine procurement
- Study at a Pakistani Hospital: COVID-19 Positive Cases Among Children Peaked During the Fifth Wave
- Pakistan Wants a More Representative Global Order: Ishaq Dar
- Debate Over Increasing the Number of Provinces in Pakistan